NGM · Biotechnology

VERA (VERA) Stock

$30.35 +1.34% NGM: VERA Healthcare

Valuation

MetricValue
Price$30.35
Market Cap$2.18B
P/E Ratio-11.48
P/B Ratio5.27
P/S Ratio0.00
EPS (TTM)$-5.54
52-Week High$56.05
52-Week Low$18.76
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-71.32%
ROA-38.90%
ROCE-52.19%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.15
Current Ratio13.64

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-34.0M$-91.0M$-102.0M$-167.0M$-315.0M
Net Profit$-33.0M$-89.0M$-96.0M$-152.0M$-300.0M
EPS$-2.43$-3.35$-2.25$-2.75$-4.66
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$84.0M$131.0M$176.0M$656.0M$735.0M
Total Liabilities$14.0M$55.0M$74.0M$79.0M$130.0M
Cash$80.0M$43.0M$46.0M$93.0M$355.0M
Borrowings$5.0M$31.0M$54.0M$55.0M$77.0M

Latest News

Vera Therapeutics Wins FDA Approval for TRUTAKNA in IgA Nephropathy, Sets Launch MarketBeat · Jul 11, 2026 Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jul 10, 2026 Is FDA Accelerated Approval Of TRUTAKNA Transforming The Investment Case For Vera Therapeutics (VERA)? Simply Wall St. · Jul 10, 2026 Vera Therapeutics (VERA) Could Be 92% Below Fair Value After FDA Approval Simply Wall St. · Jul 10, 2026 Vera Therapeutics (VERA) Stock Looks Fully Valued After Its 185% Run Simply Wall St. · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-24.0M$-68.0M$-92.0M$-135.0M$-241.0M
Investing Cash Flow$-4.0M$-71.0M$-39.0M$-426.0M$194.0M
Financing Cash Flow$-2.0M$-4.0M$-6.0M$-26.0M$0
Net Cash Flow$26.0M$-36.0M$2.0M$47.0M$262.0M
Free Cash Flow$-24.0M$-68.0M$-92.0M$-136.0M$-242.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.08
EV / EBITDA-5.52
FCF Yield-11.15%
Quick Ratio13.64
Interest Coverage-39.37
Return 1Y61.75%
Return 3Y115.77%
Return 5Y104.86%

Ownership

Insiders Held0.78%
Institutions Held110.70%
Institutions Float Held111.57%
Institutional HolderSharesReport Date
Avoro Capital Advisors LLC5,888,8882026-03-31
Blackrock Inc.5,088,1022026-03-31
Price (T.Rowe) Associates Inc4,574,0302026-03-31
Deep Track Capital, Lp4,106,0672026-03-31
Deerfield Management Company, L.P3,722,1002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABCL $6.93 +6.13% -5.91 $2.12B 0.00%
BHVN $14.07 +3.19% -6.11 $2.12B 0.00%
CLDX $35.80 +0.63% -7.84 $2.38B 0.00%
HRMY $38.24 -1.39% 11.23 $2.21B 0.00%
IMNM $23.22 +2.83% -8.13 $2.22B 0.00%

About VERA

VERA stock trades at $30.35 with a market capitalization of $2.18B. The stock is valued at a price-to-earnings (P/E) ratio of -11.48, price-to-book of 5.27, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $18.76 and $56.05, and currently trades 45.9% below its 52-week high.

On profitability, VERA generates a return on equity (ROE) of -71.32%, return on capital employed of -52.19%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides